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One Step Forward or Two Steps Back?*Gilles Rioufol, MD, PHD, Gérard Finet, MD, PHDSEE PAGE 1894I n acute coronary occlusion, ST-segment eleva-tion myocardial infarction (STEMI) has beenexperimentally and clinically correlated with
ischemic myocardial mass (area at risk), coronary
reperfusion delay, and collateral circulation (1). Rapid
coronary reperfusion, usually by primary percuta-
neous coronary intervention (PPCI), provides the
principal means of limiting infarct size and improving
prognosis. It may, however, induce reperfusion
lesions, accounting for up to 40% to 50% of ﬁnal
infarct size (2), making this a major research issue
in therapeutic development (3). Much has been
learned thanks to cardiac magnetic resonance (CMR)
imaging, which notably enables noninvasive assess-
ment of the area at risk and reperfusion lesions
(microvascular obstruction [MVO]) that develop in
the days after STEMI, and, later, speciﬁcs regarding
infarct size (4).
In treating reperfusion lesions, however, the ﬁrst
minutes after coronary reperfusion are critical (1),
thus making CMR ill-suited for detecting these
lesions in acute MVO; consequently, other tools
adapted for use in PPCI are now the focus of research
and development.
ENDOCORONARY PHYSIOLOGY TOOLS. Endocoro-
nary physiological measurements based on pressure
wires could meet this aim. Presence and severity of
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(IMR) (6–10), making these promising candidates for
assessing reperfusion lesions.
IMR has been of particular interest, as it shows less
variation than CFR (11,12). During PPCI, IMR
correlates with infarct size (6,7,10) and also with
improvement in left ventricular function (6–8,11,12).
Recently, Fearon et al. (13) and Fukunaga et al. (10)
showed that IMR is a prognostic factor for heart
failure and death. When resistance is high, IMR
increases and CFR decreases. IMR is typically <25 but
may be double that in STEMI, with a cutoff between
32 and 40 (6,9,10,12,13).
Whereas iterative measurements can be taken for
CMR (6,7), knowledge of microcirculation post-STEMI
using invasive IMR is usually limited to a single
measurement taken at PPCI. Evolution and agree-
ment with CMR results, however, are essential to
improving understanding of the physiopathology of
reperfusion lesions.SERIAL PHYSIOLOGICAL MEASUREMENT AND CMR. From
this point of view, the study by Cuculi et al. (14) in
this issue of the Journal is exemplary. The authors
report follow-up of 82 acute STEMI patients in
whom the culprit artery was studied on CFR, IMR,
and fractional ﬂow reserve (FFR) both during PPCI
and on post-intervention day 1 and month 6, with
CMR measuring edema, MVO, and infarct size almost
simultaneously during the 2 follow-up assessments.
The authors successfully met the challenge of
obtaining all of these measurements for almost half
of the baseline population, with excellent reperfusion
criteria making their ﬁndings easily generalizable.
The 6-month lack of restenosis on angiography
almost certainly rules out any focal epicardial
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FIGURE 1 IMR Measurements in Literature According to
the Presence or Absence of MVO on Cardiac Magnetic
Resonance Imaging
Values are mean  SD (except McGeoch et al. [6], which is me-
dian). IMR ¼ index of microvascular resistance; MVO ¼ micro-
vascular obstruction. *p < 0.05. **p < 0.01.
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1906resistance effect, reinforcing the idea that analysis
should focus on microcirculation. Ischemia duration
and area at risk on CMR, collaterality assessed on
FFR, MVO, and ﬁnal infarct size were all measured,
providing data of virtually experimental quality.
We can draw a number of lessons from this study.
The ﬁrst is that FFR evolves: in MVO without
epicardial stenosis, FFR diminishes signiﬁcantly
over time. This reﬂects the epicardial resistance
induced by diffuse coronary atheroma seen in the
progressive normalization of residual hyperemia
capacity.
Evolution of IMR and CFR after PPCI is another
interesting point, showing that microcirculation and
its vasodilatory capacity begin to rally as of day 1,
with improvement continuing to 6 months, recov-
ering normal values (IMR 24  22 and CFR 3.1  1.1).
This evolution was already partially known for CFR
(15,16) but, although expected, had not been previ-
ously demonstrated for IMR. This new work by
Cuculi et al. (14), unlike earlier studies (6,8–10),
found no difference in IMR according to presence/
absence of MVO (p ¼ 0.07) (Figure 1). However, while
the presence of MVO in 47% of patients was as-
sociated with higher IMR and lower CFR, both
nevertheless improved detection, reaching values
comparable to those of patients free of MVO by
6 months. Such variation and scatter in IMR values
probably makes it unreliable as a substitute for
CMR in assessing reperfusion lesion severity,
although its prognostic value seems increasingly
conﬁrmed (10,13).
Thus, Cuculi et al. (14) are reporting important
pathophysiologic ﬁndings that bolster our un-
derstanding of microcirculation after myocardial
infarction. A single invasive measure of microcircu-
lation by IMR, CFR, or FFR thus now seems anunsatisfactory way of identifying patients at high risk
of MVO. Even so, invasive assessment remains an
important focus of research, as the moment of PPCI is
a unique opportunity for detecting reperfusion
lesions and setting up the therapeutic measures
needed to treat them.
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